Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Denmark France Germany +7
  • Study on Bezafibrate for Patients with Primary Biliary Cholangitis Not Responding Well to Ursodeoxycholic Acid

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of Elafibranor for Adults with Primary Biliary Cholangitis

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark France Greece +8
  • Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

    Recruiting

    1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Greece Hungary Italy Spain
  • Study on the Safety and Effectiveness of Saroglitazar Magnesium for Patients with Primary Biliary Cholangitis

    Not recruiting

    4 1
    Investigated Diseases:
    Investigated Drugs:
    Iceland
  • Study on the Long-Term Safety of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Belgium Croatia Czechia Estonia France Germany +6
  • Study on the Effects of Bezafibrate and Obeticholic Acid for Patients with Primary Biliary Cholangitis

    Not recruiting

    2 1 1 1
    Italy
  • Study on Elafibranor for Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid

    Not recruiting

    4 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy Spain
  • Study on the Effects of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis Who Cannot Tolerate Ursodeoxycholic Acid

    Not recruiting

    2 1 1
    Investigated Diseases:
    Belgium Croatia Czechia Estonia France Germany +6
  • Study on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +6